Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001564590-16-024999
Filing Date
2016-09-07
Accepted
2016-09-07 17:16:53
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 xene-424b5_20160907.htm 424B5 1060127
2 GRAPHIC gy3mbvvxtp4v000003.jpg GRAPHIC 3687
3 GRAPHIC gy3mbvvxtp4v000001.jpg GRAPHIC 3610
4 GRAPHIC gy3mbvvxtp4v000002.jpg GRAPHIC 1946
  Complete submission text file 0001564590-16-024999.txt   1074279
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-208376 | Film No.: 161874129
SIC: 2834 Pharmaceutical Preparations